Evidence map›Paper›PMID 42661279›Full record

ArticleThe Journal of dermatology2026

RETRACTION: Comparative Efficacy of Janus Kinase Inhibitors Indicated for Severe Alopecia Areata: A Bayesian Network Meta-Analysis and Matching-Adjusted Indirect Comparison.

Abstract readRetraction Notice
In one paragraph

Article in The Journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

retractionA. Babul, D. Mehta, Y. Soliman, M. Hussain, and N. Babul, "Comparative Efficacy of Janus Kinase Inhibitors Indicated for Severe Alopecia Areata: A Bayesian Network Meta-Analysis and Matching-Adjusted Indirect Comparison," The Journal of Dermatology (Early View): https://doi.org/10.1111/1346-8138.17959. The above article, published online on 11 October 2025 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Dr. Takafumi Kadono; the Japanese Dermatological Association; and John Wiley & Sons Australia, Ltd.. The journal received concerns from authors of a separate article published in another Wiley journal [1] that this article may have plagiarized results from their own work. The concerns include direct numerical overlap of their core results reported in Table 3, Table 4, and Figure 2 as well as use without permission or attribution of the private individual patient data (IPD) for ritlecitinib that only the authors of the previously published article had access to, due to proprietary agreements. When the authors were asked for their response to the concerns, cooperated fully, acknowledged that they did not have access to the proprietary individual patient data for ritlecitinib, should not have implied that all of their comparative data analysis was performed de novo, and should have provided explicit attribution for data in Table 3, Table 4, and Figure 2. Because the data and analysis was taken without either permission or attribution, and because readers were misled about the analysis reported, the Editor-in-Chief has lost confidence in the article and its conclusions. Therefore, the article must be retracted. Upon being informed of this decision the authors disagreed with the decision to retract and instead suggested issuance of a correction as the appropriate remedy. [1] D. Aceituno, C.G. Fawsitt, G.M. Power, E. Law, S. Vaghela, and H. Thom, "Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata," Journal of The European Academy of Dermatology & Venereology 39, no. 6 (2025): 1134-1142, https://doi.org/10.1111/jdv.20372.

Identifiers

PMID42661279
PMCPMC13555096

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.